SC
INDV icon

Steven Cohen’s Indivior Pharmaceuticals INDV Stock Holding History

Steven Cohen’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.3M Buy
1,250,639
+1,155,696
+1,217% +$41.9M 0.06% 419
2026
Q1 		$2.89M Sell
94,943
-1,726,929
-95% -$57M ﹤0.01% 2064
2025
Q4 		$65.4M Sell
1,821,872
-1,040,703
-36% -$31.8M 0.07% 311
2025
Q3 		$69M Sell
2,862,575
-710,284
-20% -$14.9M 0.12% 197
2025
Q2 		$52.7M Buy
3,572,859
+1,686,628
+89% +$19.6M 0.1% 242
2025
Q1 		$18M Buy
+1,886,231
New +$19.8M 0.04% 480

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steven Cohen's INDV Position: Q2 2026 in Review

Steven Cohen increased its Indivior Pharmaceuticals (INDV) stake by 1,217% in Q2 2026, buying an estimated $41.9M and bringing the position to 1,250,639 shares worth $51.3M. The position accounts for 0.06% of the portfolio, ranked #419.

Steven Cohen first reported a position in INDV in Q1 2025 and has held it in 6 quarters since. The position peaked at $69M in Q3 2025. 335 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Steven Cohen held 1,250,639 shares of Indivior Pharmaceuticals worth $51.3M as of Q2 2026.
  • Steven Cohen bought 1,155,696 Indivior Pharmaceuticals shares in Q2 2026, an estimated $41.9M.
  • Indivior Pharmaceuticals made up 0.06% of Steven Cohen's portfolio in Q2 2026, its #419 holding.
  • Steven Cohen first reported a position in Indivior Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Steven Cohen's Indivior Pharmaceuticals position peaked at $69M in Q3 2025.
  • 335 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.